US Nephrectomy Market

ID: MRFR/MED/11746-HCR

100 Pages

Garvit Vyas

October 2025

US Nephrectomy Market Research Report: By Procedure (Open Nephrectomy, Laparoscopic nephrectomy, Robot-assisted Laparoscopic Surgery), By Indication (Kidney Cancer, Kidney Disease) and By End User (Hospitals, Clinics, Surgical Centers) - Forecast to 2035

Summary Table of Contents Segmentation Download PDF

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Certified Researchers

Customize Report

US Nephrectomy Market Summary

The US Nephrectomy market is projected to grow significantly from 644.4 million USD in 2024 to 1123.2 million USD by 2035.

Key Market Trends & Highlights

US Nephrectomy Key Trends and Highlights

The US Nephrectomy market is valued at 644.4 million USD in 2024.
By 2035, the market is expected to reach 1123.2 million USD, indicating robust growth.
The compound annual growth rate (CAGR) for the period from 2025 to 2035 is estimated at 5.18%.
Growing adoption of advanced surgical techniques due to increasing prevalence of kidney diseases is a major market driver.

US Nephrectomy Market

CAGR

5.18%

Market Size & Forecast

2024 Market Size	644.4 (USD Million)
2035 Market Size	1123.2 (USD Million)
CAGR (2025-2035)	5.18%

Major Players

Hologic, Integra LifeSciences, Boston Scientific, Medtronic, Abbott Laboratories, Baxter International, Acelity, Thermo Fisher Scientific, Stryker, ConMed, Siemens Healthineers, Cook Medical, Johnson and Johnson, Ethicon, Intuitive Surgical

Market Segment Insights

Nephrectomy Market Procedure Insights

The US Nephrectomy Market, particularly the Procedure segment, plays a critical role in the treatment strategies for kidney-related disorders. Procedures like Open Nephrectomy, Laparoscopic Nephrectomy, and Robot-assisted Laparoscopic Surgery are essential methods employed in the surgical management of renal diseases.

Open Nephrectomy, a traditional approach, enables surgeons to directly access the kidneys and may be utilized in complicated cases where extensive visualization is necessary. This method, while effective, is known for a longer recovery period due to increased surgical trauma.

Conversely, Laparoscopic Nephrectomy, which involves smaller incisions, is gaining traction in the market due to its advantages such as decreased postoperative pain, shortened recovery times, and minimal scarring. This technique allows for a better cosmetic outcome while maintaining high efficacy in kidney removal.

The newer innovation of Robot-assisted Laparoscopic Surgery is rapidly emerging as a preferred solution, as it enhances precision through advanced robotic technology, improving surgical outcomes and reducing the potential for complications.This has made Robot-assisted Laparoscopic Surgery particularly appealing to institutions striving for improved patient care.

The US Nephrectomy Market is also being driven by factors such as the aging population, an increase in the prevalence of kidney disease, and greater public awareness of surgical options. However, it faces challenges like high costs associated with advanced technologies and varying degrees of surgeon experience with newer techniques.

Nephrectomy Market Indication Insights

The US Nephrectomy Market is primarily driven by various indications, with significant focus on conditions such as Kidney Cancer and Kidney Disease. Kidney Cancer has become a leading indication for nephrectomy procedures, reflecting a rising incidence of renal cell carcinoma across the population.

This trend aligns with increased awareness and advancements in diagnostic imaging, leading to earlier detection and treatment options. Concurrently, Kidney Disease, including chronic kidney disease, is a considerable contributor to the demand for nephrectomy, as patients progress to stages that necessitate surgical intervention.

The combination of an aging population, lifestyle factors, and a growing prevalence of diabetes and hypertension creates a substantial burden of kidney-related health issues in the US. These factors not only necessitate surgical procedures but also drive innovations in treatment technologies, enhancing patient outcomes.

The diverse indications within the nephrectomy market highlight the importance of surgical interventions in managing these life-threatening and chronic conditions. Overall, the US Nephrectomy Market segmentation reflects a landscape shaped by both rising patient needs and continuous advancements in medical practices and technologies.

Nephrectomy Market End User Insights

The End User segment of the US Nephrectomy Market encompasses various healthcare settings, particularly hospitals, clinics, and surgical centers, each playing a crucial role in delivering nephrectomy procedures. Hospitals are the primary environments for surgical interventions, equipped with advanced technology, critical care facilities, and specialized staff to handle complex cases.

Clinics increasingly offer minimally invasive nephrectomy options, catering to the growing demand for outpatient services, which reflects a significant trend towards improved patient convenience and reduced hospital stays.Surgical centers provide a valuable alternative, focusing on same-day discharge solutions that enhance efficiency and patient turnover.

The US Nephrectomy Market, characterized by rising incidences of kidney diseases and increased awareness of surgical options, is expected to see growth driven by technological advancements and the need for specialized care in these settings. As a result, hospitals and surgical centers are often viewed as key players due to their capacity to address the complexities of nephrectomy procedures effectively.

The segmentation of the market highlights the unique attributes of each category, emphasizing the diversity of approaches in delivering nephrectomy services across the nation.This dynamic landscape reflects the adaptability of the US healthcare system in meeting patient needs while advancing surgical care options.

Get more detailed insights about US Nephrectomy Market

Request Free Sample

Key Players and Competitive Insights

The US Nephrectomy Market is a segment characterized by the surgical removal of one or both kidneys, which can be necessitated by various conditions, including renal cancer and kidney diseases. The competitive landscape of this market is shaped by advancements in surgical methods, technologies, and an increasing demand for minimally invasive procedures.

As healthcare providers focus on improving patient outcomes, there is a heightened emphasis on innovation and efficiency in nephrectomy procedures. The market is populated by numerous companies that contribute to the development of surgical instruments, imaging technologies, and associated products designed specifically for nephrectomy, thereby intensifying competition among key players striving to capture market share in this specialized field.

Hologic

Hologic has established a significant presence in the US Nephrectomy Market through its innovative product offerings and commitment to advancing medical technologies. The company is well-regarded for its focus on women's health and has made strides in expanding its portfolio to address nephrectomy needs effectively.

Hologic leverages state-of-the-art imaging technologies and minimally invasive surgical solutions that cater specifically to renal surgeons and healthcare institutions. Its strong emphasis on research and development enables Hologic to maintain a competitive edge, ensuring that its products not only meet industry standards but also enhance patient care quality.

This dedication to innovation, coupled with strategic collaborations and partnerships within the healthcare sector, positions Hologic as a formidable player in the US Nephrectomy Market.

Integra LifeSciences

Integra LifeSciences is a prominent entity within the US Nephrectomy Market, recognized for its comprehensive range of surgical products and services catering to kidney surgery. The company offers various solutions, including advanced surgical instruments and biomaterials that support nephrectomy procedures.

With its steadfast commitment to quality and innovation, Integra LifeSciences capitalizes on its extensive expertise in tissue regeneration and surgical technologies. The company's robust market presence is further bolstered by targeted mergers and acquisitions, which enhance its portfolio and operational capabilities in the nephrectomy domain.

Integra's focus on providing high-quality products that meet the needs of surgeons and healthcare facilities underpins its strengths, ensuring it remains a competitive force in the US Nephrectomy Market.

Key Companies in the US Nephrectomy Market market include

Industry Developments

In the US Nephrectomy Market, recent developments highlight the growing interest in minimally invasive surgical techniques. Notable advancements include the increased adoption of robotic-assisted surgical systems, such as those offered by Intuitive Surgical, which enhance precision and reduce patient recovery times.

Current market dynamics show strong growth, influenced by increasing incidences of kidney diseases and associated treatments. Furthermore, Baxter International has expanded its portfolio of renal care solutions to address this growing demand.

In terms of mergers and acquisitions, Hologic announced the acquisition of a smaller firm in September 2023, enhancing its capabilities in women's health and kidney disease. Similarly, in June 2023, Siemens Healthineers finalized a strategic acquisition aimed at bolstering its medical imaging division, which plays a crucial role in nephrology.

Over the last couple of years, the Nephrectomy Market in the US has witnessed significant growth, particularly since the onset of the COVID-19 pandemic, which emphasized the need for advanced surgical solutions. Reports indicate that the market is expected to continue expanding rapidly, driven by technological innovations and increasing healthcare expenditures, fostering a competitive landscape among key players like Medtronic, Boston Scientific, and Johnson and Johnson.

Market Segmentation

Nephrectomy Market End User Outlook

Hospitals
Clinics
Surgical Centers

Nephrectomy Market Procedure Outlook

Open Nephrectomy
Laparoscopic nephrectomy
Robot-assisted Laparoscopic Surgery

Nephrectomy Market Indication Outlook

Kidney Cancer
Kidney Disease

Report Scope

Report Scope:

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	618.38(USD Million)
MARKET SIZE 2024	644.35(USD Million)
MARKET SIZE 2035	1123.19(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.182% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Hologic, Integra LifeSciences, Boston Scientific, Medtronic, Abbott Laboratories, Baxter International, Acelity, Thermo Fisher Scientific, Stryker, ConMed, Siemens Healthineers, Cook Medical, Johnson and Johnson, Ethicon, Intuitive Surgical
SEGMENTS COVERED	Procedure, Indication, End User
KEY MARKET OPPORTUNITIES	Robotic-assisted surgical systems, Advanced imaging technologies, Enhanced postoperative care solutions, Increasing kidney disease prevalence, Growing demand for minimally invasive procedures
KEY MARKET DYNAMICS	rising incidence of kidney diseases, technological advancements in surgical techniques, increasing healthcare expenditure, growing awareness among patients, regulatory approvals and guidelines
COUNTRIES COVERED	US

FAQs

What is the current market value of the US Nephrectomy Market?

As of 2024, the US Nephrectomy Market is valued at approximately 644.35 million USD.

What is the projected market value of the US Nephrectomy Market by 2035?

The market is expected to reach around 1123.19 million USD by the year 2035.

What is the expected CAGR for the US Nephrectomy Market from 2025 to 2035?

The compound annual growth rate for the market from 2025 to 2035 is projected at 5.182%.

Which procedure is expected to dominate the US Nephrectomy Market by value?

Laparoscopic nephrectomy is anticipated to hold a significant share, valued at 310 million USD in 2024 and expected to grow to 550 million USD by 2035.

What are the market values for open nephrectomy from 2024 to 2035?

Open nephrectomy is valued at 220 million USD in 2024, increasing to 380 million USD by 2035.

How much is the robot-assisted laparoscopic surgery segment valued in 2024?

Robot-assisted laparoscopic surgery is valued at 114.35 million USD in 2024, with projections of reaching 193.19 million USD by 2035.

Who are the key players in the US Nephrectomy Market?

Major players in the market include Hologic, Integra LifeSciences, Boston Scientific, and Medtronic among others.

Are there any emerging trends influencing the US Nephrectomy Market?

Emerging trends include advancements in minimally invasive surgical techniques and increasing demand for robotic surgery.

What potential challenges face the US Nephrectomy Market?

Challenges include high costs of surgical procedures and the need for skilled professionals to perform advanced surgeries.

What growth opportunities exist for the US Nephrectomy Market?

There are growth opportunities in adopting new technologies and expanding access to nephrectomy procedures in various healthcare settings.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓